• We are available for your help 24/7
  • Email: info@isindexing.com, submission@isindexing.com

Paper Details


K. P. R. Chowdary*, K. Ravi Shankar and V. V. L. S. P. Sowjanya

Journal Title:World Journal of Pharmaceutical Research

Irbesartan, a widely prescribed anti hypertensive drug belongs to class II under BCS classification and exhibit low and variable oral bioavailability due to its poor aqueous solubility. It needs enhancement in the dissolution rate in its formu lation development. Complexation with ?-cyclodextrin (?CD) and use of Crospovidone are tried for enhancing the dissolution rate of irbesartan in its formulation development. The objective of the present study is optimization of irbesartan tablet formulatio n employing Crospovidone and ?CD by 22 factorial design. Formulation of irbesartan tablets (i) with NLT 85% dissolution in 15 min and (ii) with NLT 70% dissolution in 15 min employing Crospovidone and ?CD in each case was optimized by 22 factorial design. Four irbesartan tablet formulations were prepared using selected combinations of the two factors as per 2 2 factorial design. Irbesartan tablets were prepared by direct compression method and were evaluated for drug content, hardness, friability, disintegration time and dissolution rate characteristics. Irbesartan tablets formulated employing Crospovidone at a level of 30% of drug content and ?CD in 1:1 ratio of drug: ?CD (Fa) disintegrated rapidly within 20 seconds and gave very rapid dissolution of irbesartan, 97.18% in 15 min. Higher levels of ?CD and lower levels of Crospovidone gave low dissolution rates of irbesartan tablets. The increasing order of dissolution rate (K1) observed with various formulations was F a> Fab> F1> Fb.The polynomial equation describing the relationship between the response i.e. percent drug dissolved in 15min (Y) and the levels of rospovidone (X1) and ?CD (X2) based on the observed results is Y=60.37+33.04 (X1) 5.03 (X2) + 1.265 (X 1 X2). Based on the above polynomial equation, two optimized Irbesartan tablet formulations, One with high dissolution (OPT1) with NLT 85% dissolution in 15 min could be formulated employing Crospovidone at 24.75% of drug content and ?CD at 1:1 ratio of drug:?CD and the other with moderate dissolution (OPT2) with NLT 70% dissolution in 15 min could be formulated employing Crospovidone at 19.07% of drug content and ?CD at 1:2 ratio of drug: ?CD .The optimized irbesartan tablet formulation,OPT1 gave 88.27% dissolution in 15 min and formulation OPT2 gave 73.48% dissolution in 15 min fulfilling the target dissolution set in each case.The results indicated validity of the optimizatio n technique employed and the polynomial equation developed could be used to formulate Irbesartan tablets with any desired dissolution rate specification. Hence formulation of irbesartan tablets with any desired dissolution rate specification could be optim ized by 22 factorial design.